| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Brian Lian is President & CEO at VKTX. From May 2015 to July 2026, the filings on record show 0 open-market purchases and 18 sales. Brian Lian's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $67.1M at current prices.
Historically, Brian Lian's trades have earned a middling insider score of 54/100 across 20 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -30.7%.
The VKTX filings lean toward selling, a net 2,079,920 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | VKTX Viking Therapeutics, Inc. | President & CEO | Sale+OE10b5-1 | 269,079 | $26.87 | $7,230,784.25 | -11.0% | +176.6% | +12.7% | |
| Jan 31, 2024 | VKTX Viking Therapeutics, Inc. | President & CEO | Sale+OE10b5-1 | 85,000 | $24.71 | $2,100,750.00 | -3.6% | +229.7% | +39.6% | |
| Jan 30, 2024 | VKTX Viking Therapeutics, Inc. | President & CEO | Sale+OE10b5-1 | 35,000 | $23.95 | $838,250.00 | -1.5% | +216.6% | +40.3% | |
| May 1, 2023 | VKTX Viking Therapeutics, Inc. | President & CEO | Sell | 45,000 | $22.45 | $1,010,250.00 | -2.0% | -34.4% | +259.8% | |
| Apr 19, 2023 | VKTX Viking Therapeutics, Inc. | President & CEO | Sell | 35,000 | $21.45 | $750,750.00 | -1.5% | -27.6% | +204.0% | |
| Apr 17, 2023 | VKTX Viking Therapeutics, Inc. | President & CEO | Sale+OE | 155,000 | $20.45 | $3,169,765.50 | -6.4% | -21.1% | +246.2% | |
| Apr 13, 2023 | VKTX Viking Therapeutics, Inc. | President & CEO | Sale+OE | 79,336 | $18.45 | $1,463,749.20 | -3.3% | -17.3% | +268.5% | |
| Apr 3, 2023 | VKTX Viking Therapeutics, Inc. | President & CEO | Sale+OE | 243,352 | $17.31 | $4,211,292.40 | -9.8% | -12.1% | +340.2% |